Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.

Por Federici, A B, Elder, J H, De Marco, L, Ruggeri, Z M, Zimmerman, T S
Publicado em 1984

Gene deletions correlate with the development of alloantibodies in von Willebrand disease.

Por Shelton-Inloes, B B, Chehab, F F, Mannucci, P M, Federici, A B, Sadler, J E
Publicado em 1987

Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.

Por De Marco, L, Mazzucato, M, De Roia, D, Casonato, A, Federici, A B, Girolami, A, Ruggeri, Z M
Publicado em 1990

Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level

Por Calabrò, G. E., La Torre, G., de Waure, C., Villari, P., Federici, A., Ricciardi, W., Specchia, M. L.
Publicado no BMC Health Serv Res (2018)

Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct...

Por De Marco, L, Mazzuccato, M, Grazia Del Ben, M, Budde, U, Federici, A B, Girolami, A, Ruggeri, Z M
Publicado em 1987

von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for pla...

Por de Groot, P G, Federici, A B, de Boer, H C, d'Alessio, P, Mannucci, P M, Sixma, J J
Publicado em 1989

Current state of genomic policies in healthcare among EU member states: results of a survey of chief medical officers

Por Mazzucco, W., Pastorino, R., Lagerberg, T., Colotto, M., d’Andrea, E., Marotta, C., Marzuillo, C., Villari, P., Federici, A., Ricciardi, W., Boccia, S.
Publicado no Eur J Public Health (2017)

von Willebrand’s disease: a report from a meeting in the Åland islands

Por BERNTORP, E., PEAKE, I., BUDDE, U., LAFFAN, M., MONTGOMERY, R., WINDYGA, J., GOODEVE, A., PETRINI, P., DEPKA, M.VON, MIESBACH, W., LILLICRAP, D., FEDERICI, A. B., LASSILA, R., WHITE, G.
Publicado em 2012

Third Åland islands conference on von Willebrand disease, 26–28 September 2012: meeting report

Por BERNTORP, E., FUCHS, B., MAKRIS, M., MONTGOMERY, R., FLOOD, V., O’DONNELL, J. S., FEDERICI, A. B., LILLICRAP, D., JAMES, P., BUDDE, U., MORFINI, M., PETRINI, P., AUSTIN, S., KANNICHT, C., JIMÉNEZ-YUSTE, V., LEE, C.
Publicado em 2013

Prophylaxis in severe forms of von Willebrand’s disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)

Por ABSHIRE, T. C., FEDERICI, A. B., ALVÁREZ, M. T., BOWEN, J., CARCAO, M. D., GILL, J. COX, KEY, N. S., KOUIDES, P. A., KURNIK, K., LAIL, A. E., LEEBEEK, F. W. G., MAKRIS, M., MANNUCCI, P. M., WINIKOFF, R., BERNTORP, E.
Publicado no Haemophilia (2012)